Geneva, June 22 -- International Clinical Trials Registry received information related to the study (ChiCTR2600126445) titled 'Adaptive Research on Risk Prediction of Deep Vein Thrombosis and immunomodulatory Therapy Based on Multimodal electronic Health Data' on June 9.
Study Type: Observational study
Study Design:
Sequential
Primary Sponsor: Quanzhou First Hospital, Fujian
Condition:
deep venous thrombosis
Recruitment Status: Not Recruiting
Phase: 0
Date of First Enrollment: 2027-01-01
Target Sample Size: Non-DVT Patient Group vs. DVT Patient Group:10000;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=323779
Published by HT Digital Content Services with permission from H...